Pfizer Inc Stock Price Today (PFE PFE.BE 0Q1N.IL)
2023.03.07 10:03
Pfizer Inc. is a multinational American pharmaceutical and biotechnology company with headquarters in Manhattan, New York City, on 42nd Street. Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891), two German businessmen, founded the company in 1849 in New York.
Medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology are developed and manufactured by Pfizer. The Pfizer–BioNTech COVID-19 vaccine (37 billion dollars in 2022 revenues), Nirmatrelvir/ritonavir (18 billion dollars in 2022 revenues), Apixaban (6 billion dollars in 2022 revenues), a pneumococcal conjugate vaccine (6 billion dollars in 2022 revenues), and Palbociclib (5 billion dollars in 2022 revenues) are the company’s most popular products in terms of sales. In 2022, the United States accounted for 42% of the business’s revenue, Japan for 8%, and other nations for 50%.
From 2004 to August 2020, Pfizer was a part of the Dow Jones Industrial Average stock market index. The business is ranked 43rd on the Forbes Global 2000 and 43rd on the Fortune 500.
